DocSym
β
Searchsearch
Search
(Q22) Congenital malformations of pulmonary and tricuspid valves
More details coming soon
258 814 in individuals diagnosis congenital malformations of pulmonary and tricuspid valves confirmed
5 601 deaths with diagnosis congenital malformations of pulmonary and tricuspid valves
2% mortality rate associated with the disease congenital malformations of pulmonary and tricuspid valves
Diagnosis congenital malformations of pulmonary and tricuspid valves is diagnosed Men are 2.44% more likely than Women
132 569
Men receive the diagnosis congenital malformations of pulmonary and tricuspid valves
3 043 (2.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
126 245
Women receive the diagnosis congenital malformations of pulmonary and tricuspid valves
2 558 (2.0 %)Died from this diagnosis.
Risk Group for the Disease congenital malformations of pulmonary and tricuspid valves - Men and Women aged 0
In Men diagnosis is most often set at age 0-79
Less common in men the disease occurs at Age 80-95+Less common in women the disease occurs at Age 80-95+
In Women diagnosis is most often set at age 0-79
Disease Features congenital malformations of pulmonary and tricuspid valves
Absence or low individual and public risk
Congenital malformations of pulmonary and tricuspid valves - what does this mean
Congenital malformations of pulmonary and tricuspid valves occur when the valves of the heart do not form correctly during fetal development, leading to abnormal openings or incomplete closure of the valves. this can result in blood flowing in the wrong direction and can lead to heart failure, arrhythmias, and other complications.
What happens during the disease - congenital malformations of pulmonary and tricuspid valves
Congenital malformations of the pulmonary and tricuspid valves are caused by abnormal development of the valves during fetal development. the abnormal development can be due to genetic mutations, environmental factors, or a combination of the two. this can lead to structural problems with the valves, resulting in difficulty in blood flow from the right side of the heart to the lungs, and from the lungs back to the left side of the heart. this can result in symptoms such as shortness of breath, fatigue, and swelling of the legs.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Chest X-ray
- Echocardiogram
- Cardiac MRI
- Cardiac catheterization
- Electrocardiogram (ECG)
- Blood tests
Treatment and Medical Assistance
Main goal of the treatment: To improve the functioning of the pulmonary and tricuspid valves.
- Regular monitoring of the patient’s condition
- Medication to reduce pulmonary and tricuspid valve regurgitation
- Surgery to repair the valves
- Medication to reduce inflammation and improve the functioning of the valves
- Physical therapy to strengthen the heart muscles
- Lifestyle changes to reduce the risk of complications
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Congenital malformations of pulmonary and tricuspid valves - Prevention
The best way to prevent congenital malformations of pulmonary and tricuspid valves is through prenatal care. this includes regular ultrasounds and other tests to monitor fetal development, as well as regular visits to a doctor to detect any potential issues. additionally, pregnant women should receive adequate nutrition and take prenatal vitamins, as well as avoid smoking and alcohol consumption.